Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.42236 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.63586 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.63795 | 28 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.28212 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.55372 | 26 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.68169 | 27 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.40832 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.55127 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.76212 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.62304 | 28 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.2766 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.77919 | 36 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.60353 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.99447 | 43 |